FDA issued a Warning Letter to Valeant Pharmacueticals International on 11/3/2016 as a result of this inspection.
FDA investigators audited the Valeant Pharmacueticals North America - Rochester, NY, United States facility and issued 3 inspectional observations (via FDA 483) on 01 Sep 2016.
Product details
- Category: Medical Devices & Rad Health
- Number of Observations: 3
- Inspection end: 01 Sep 2016
- Location: Rochester, United States
- FEI: 3009443653
